The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Human vascular smooth muscle cells contain functional estrogen receptor.
Abstract
BACKGROUND: The decreased incidence of coronary artery disease observed in postmenopausal women given estrogen (E2) replacement demonstrates an atheroprotective effect of E2 that is generally believed to be mediated by indirect, E2-induced changes in cardiovascular risk factor profiles. We hypothesized that the atheroprotective effect of E2 may be in part mediated by a direct effect of E2 on vascular smooth muscle cells (VSMCs). Therefore, a series of experiments was performed to determine whether human VSMCs contain a competent E2 receptor, a ligand-activated transcription factor known to mediate E2-induced effects in nonvascular cells. METHODS AND RESULTS: Ribonuclease protection assays, with a probe derived from the human E2 receptor, were used to demonstrate E2-receptor mRNA in human saphenous vein VSMCs. To show that VSMCs contain E2-receptor protein as well as message, immunoblotting and immunofluorescence studies with a monoclonal anti-E2-receptor antibody were performed, and E2-receptor protein was detected by both methods. Transient transfection assays using a specific E2-responsive reporter system were used next to determine whether the VSMC E2 receptor is capable of E2-induced transcriptional transactivation. Initial studies using mammary artery-derived VSMCs resulted in a 2.4-fold increase in reporter activity in response to 10(-7) mol/L E2. Subsequent studies using saphenous vein VSMCs demonstrated increasing levels of reporter activation as the concentration of E2 was increased from 10(-9) mol/L (1.3-fold increase; SEM, 0.07; P = .05, n = 3) to 10(-7) mol/L (1.6-fold increase; SEM, 0.04; P = .002, n = 6). The specificity of the E2-induced transactivation of the reporter gene was shown by dose-dependent inhibition of transactivation by the pure E2 antagonist ICI 164,384 and by enhancement of the transactivation by simultaneous overexpression of the E2 receptor. CONCLUSIONS: We have demonstrated for the first time that human VSMCs express E2-receptor mRNA and protein and that the E2 receptor in VSMCs is capable of estrogen-dependent gene activation. These data suggest a mechanism by which estrogen may directly alter VSMC function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Firefly luciferase gene: structure and expression in mammalian cells.
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,087
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J.-M., Argos, P., & Chambon, P. (1986) · Nature · doi:10.1038/320134a0 · Cited by 2,321
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 1,997
Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Berthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L. J., Bolado, J., Yang, N., Verma, I. M., & Evans, R. M. (1990) · Cell · doi:10.1016/0092-8674(90)90397-w · Cited by 1,221
Menopause and the Risk of Coronary Heart Disease in Women
Colditz, G. A., Willett, W. C., Stampfer, M. J., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704303161801 · Cited by 1,148
Nabulsi, A. A., Folsom, A. R., White, A., Patsch, W., Heiss, G., Wu, K. K., & Szklo, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304153281501 · Cited by 906
Steroid Receptor Family: Structure and Functions
CARSON-JURICA, M. A., SCHRADER, W. T., & O'MALLEY, B. W. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-201 · Cited by 811
Horwitz, K. B., & McGuire, W. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38062-6 · Cited by 799
Reduced levels of hsp90 compromise steroid receptor action in vivo
Picard, D., Khursheed, B., Garabedian, M. J., Fortin, M. G., Lindquist, S., & Yamamoto, K. R. (1990) · Nature · doi:10.1038/348166a0 · Cited by 787
Cloning of the human estrogen receptor cDNA.
Walter, P., Green, S., Greene, G., Krust, A., Bornert, J. M., Jeltsch, J. M., Staub, A., Jensen, E., Scrace, G., & Waterfield, M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.7889 · Cited by 730
Klein-Hitpaß, L., Schorpp, M., Wagner, U., & Ryffel, G. U. (1986) · Cell · doi:10.1016/0092-8674(86)90705-1 · Cited by 720
Glass, C. K., Holloway, J. M., Devary, O. V., & Rosenfeld, M. G. (1988) · Cell · doi:10.1016/0092-8674(88)90194-8 · Cited by 654
Decreased Mortality in Users of Estrogen Replacement Therapy
Henderson, B. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010095012 · Cited by 632
Steroid receptors and their associated proteins
Smith, D. F. (1993) · Molecular Endocrinology · doi:10.1210/me.7.1.4 · Cited by 545
Libby, P., Warner, S. J., & Friedman, G. B. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113346 · Cited by 533
Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor.
Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., Curtis, S. W., Washburn, T. F., McLachlan, J. A., & Korach, K. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4658 · Cited by 480
Immunochemical studies of estrogen receptors
Greene, G. L., Sobel, N. B., King, W. J., & Jensen, E. V. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90188-2 · Cited by 434
The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties.
Tora, L., Mullick, A., Metzger, D., Ponglikitmongkol, M., Park, I., & Chambon, P. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03604.x · Cited by 417
Stewart, A. J., Johnson, M. D., May, F. E., & Westley, B. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45342-7 · Cited by 381
Short-term administration of estrogen and vascular responce of atherosclerotic coronary arteries
Williams, J. K., Adams, M. R., Herrington, D. M., & Clarkson, T. B. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90116-5 · Cited by 357
MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASE
Ross, R., Mack, T., Paganini-Hill, A., Arthur, M., & Henderson, B. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92138-3 · Cited by 356
Steroid receptor analyses of nine human breast cancer cell lines.
Horwitz, K. B., Zava, D. T., Thilagar, A. K., Jensen, E. M., & McGuire, W. L. (1978) · PubMed · Cited by 326
Ignar-Trowbridge, D. M. (1993) · Molecular Endocrinology · doi:10.1210/me.7.8.992 · Cited by 325
Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., & Sutherland, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3577 · Cited by 297
Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression
Wahli, W., & Martinez, E. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.9.1860615 · Cited by 294
Dubik, D., Dembinski, T. C., & Shiu, R. P. C. (1987) · PubMed · Cited by 276
Effect of estradiol on human breast cancer cells in culture.
Darbre, P. D., Yates, J., Curtis, S., & King, R. J. B. (1983) · PubMed · Cited by 271
Postmenopausal Hormone-Replacement Therapy
Martin, K. A., & Freeman, M. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304153281509 · Cited by 253
Smith, C. L., Conneely, O. M., & O'Malley, B. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6120 · Cited by 242
Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids.
Horwitz, K. B., & Horwitz, L. D. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110513 · Cited by 233
Novel antioestrogens without partial agonist activity
Wakeling, A. E., & Bowler, J. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90014-3 · Cited by 214
Control of transcription activation by steroid hormone receptors
Gronemeyer, H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.8.1592204 · Cited by 214
Hong, M. K., Romm, P. A., Reagan, K., Green, C. E., & Rackley, C. E. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91300-s · Cited by 178
Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.
Kerppola, T. K., Luk, D., & Curran, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3782 · Cited by 168
Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery
Vargas, R., Wroblewska, B., Rego, A., Hatch, J., & Ramwell, P. W. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13616.x · Cited by 163
Biro, S., Fu, Y. M., Yu, Z. X., & Epstein, S. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.654 · Cited by 162
Read, L. D., Keith, D. E., Slamon, D. J., & Katzenellenbogen, B. S. (1990) · PubMed · Cited by 155
Philips, A., Chalbos, D., & Rochefort, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85214-6 · Cited by 153
The presence of functional estrogen receptors in intestinal epithelial cells
Thomas, M. L., Xu, X., Norfleet, A. M., & Watson, C. S. (1993) · Endocrinology · doi:10.1210/endo.132.1.8419141 · Cited by 146
Howard, K. J., & Distelhorst, C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69095-7 · Cited by 120
Glendy, R. E. (1937) · JAMA · doi:10.1001/jama.1937.02780480007002 · Cited by 109
Induction of the estrogen-regulated "24K" protein by heat shock.
Fuqua, S. A. W., Blum-Salingaros, M., & McGuire, W. L. (1989) · PubMed · Cited by 104
Fischer-Dzoga, K., Wissler, R. W., & Vesselinovitch, D. (1983) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(83)90064-3 · Cited by 96
Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line.
Ma, Z. Q., Spreafico, E., Pollio, G., Santagati, S., Conti, E., Cattaneo, E. F., & Maggi, A. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3740 · Cited by 82
Berthois, Y., Dong, X.-F., & Martin, P. M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92413-3 · Cited by 79
Uterine Estrogen Receptorin Vivo: Phosphorylation of Nuclear Specific Forms on Serine Residues
Washburn, T. F., Hocutt, A., Brautigan, D. L., & Korach, K. S. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-2-235 · Cited by 71
Ali, S., Lutz, Y., Bellocq, J., Chenard, M., Rouyer, N., & METZGER, D. (1993) · Hybridoma · doi:10.1089/hyb.1993.12.391 · Cited by 66
A modified immunohistochemical procedure for the detection of estrogen receptor in mouse tissues
Yamashita, S., & Korach, K. S. (1989) · Histochemistry and Cell Biology · doi:10.1007/bf00508308 · Cited by 61
Structure and function of steroid receptors
King, R. J. B. (1987) · Journal of Endocrinology · doi:10.1677/joe.0.1140341 · Cited by 56
Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver function
Cauley, J. A., LaPorte, R. E., Kuller, L. H., Bates, M. W., & Sandler, R. B. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90005-9 · Cited by 55
Farhat, M. Y., Vargas, R., Dingaan, B., & Ramwell, P. W. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14506.x · Cited by 55
c-myc oncogene expression in estrogen-dependent and -independent breast cancer
Shiu, R. P. C., Watson, P. H., & Dubik, D. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.2.353 · Cited by 53
van der Burg, B., de Groot, R. P., Isbrücker, L., Kruijer, W., & de Laat, S. W. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-11-1720 · Cited by 45
Cited by
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,103
Self-citationProduction and Actions of Estrogens
Gruber, C. J., Tschugguel, W., Schneeberger, C., & Huber, J. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmra000471 · Cited by 1,062
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
Regitz-Zagrosek, V., & Kararigas, G. (2017) · Physiological Reviews · doi:10.1152/physrev.00021.2015 · Cited by 732
The vascular protective effects of estrogen
Farhat, M. Y., Lavigne, M. C., & Ramwell, P. W. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621060 · Cited by 639
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 592
Metadata
- Authors
- Karas, R. H., Patterson, B. L., & Mendelsohn, M. E.
- Venue
- Circulation
- Published
- 1994-05
- Volume
- 89
- Issue
- 5
- Pages
- 1943-1950
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1966323574
- Cited by
- 489
- References
- 60
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.